Enhertu Wins EU Approval for Early Breast Cancer Treatment
Enhertu has received EU approval to treat HER2-positive early breast cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Daiichi Sankyo's Enhertu Wins EU Approval for Early Breast Cancer Treatment
The EU approved Enhertu for adjuvant treatment of early breast cancer.